BLISSGVS vs MEDICO: Stock Comparison

Bliss GVS Pharma Limited vs Medico Remedies Limited

Live data: 2 July 2026, 4:08 PM IST • Source: NSE and company filings

Bliss GVS Pharma Limited is the larger company by market capitalisation. Bliss GVS Pharma Limited shows a higher dividend yield and a higher net margin, while Medico Remedies Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bliss GVS Pharma Limited and Medico Remedies Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLISSGVS is more favourable on 7 of 13 scored metrics and MEDICO on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BLISSGVS is the larger company
₹4,782 Cr vs ₹317 Cr
P/E Ratio
MEDICO has a lower P/E
27.22x vs 38.27x
P/B Ratio
BLISSGVS has a lower P/B
4.14x vs 4.73x
EPS
BLISSGVS has higher earnings per share
₹11.99 vs ₹1.58
Dividend Yield
BLISSGVS has a higher dividend yield
0.19% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 29.8%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 36.5%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
37.6% vs 13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSMEDICO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSMEDICO
Live Price₹527.1₹38.18
Day Change0.68%-1.14%
Volume3.93 L16,596
52-Week High₹553₹56.88
52-Week Low₹118₹30.22
Distance from 52W High-4.68%-32.88%

Valuation

MetricBLISSGVSMEDICO
Market Cap₹4,782 Cr₹317 Cr
P/E Ratio38.27x27.22x
P/B Ratio4.14x4.73x
EPS₹11.99₹1.58
Book Value₹107.21₹9.15
Dividend Yield0.19%0%

Growth

MetricBLISSGVSMEDICO
Revenue Growth (TTM YoY)29.8%37.5%
EPS Growth (TTM YoY)124.7%36.5%
Qtr Sales Growth13%37.6%
Qtr Profit Growth108%35%

Profitability & Leverage

MetricBLISSGVSMEDICO
ROE0%19%
ROCE11.7%23.1%
Net Margin13.93%6.36%
Operating Margin12.82%8.25%
Debt to Equity1.77x0.25x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricBLISSGVSMEDICO
Promoter Holding35.36%61.38%
FII Holding10.45% 4.09 pp0.03% 0.46 pp
DII Holding5.04% 0.74 pp0%
Public Holding49.15% 4.83 pp38.59% 0.46 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bliss GVS Pharma Limited and Medico Remedies Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.